After
WuXi Biologics pushes Massachusetts factory opening to 2028 after pausing construction in 2024 for a facility redesign. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for in vivo therapies Drug…
WuXi Biologics’ factory that is under construction in Massachusetts is slated to be completed in 2028 — a decade after the company first announced its plans and would be about six years late from its original ...
Source: Endpoints News